Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Randomized comparison of cyclophosphamide versus reduced-dose cyclophosphamide plus
fludarabine in addition to anti-thymocyte globulin for the conditioning therapy in allogeneic
hematopoietic cell transplantation for bone marrow failure syndrome.